...
首页> 外文期刊>Bioconjugate Chemistry >In Situ SWYGLR Peptide Conjugation into Injectable Gelatin-Poly(ethylene glycol)-Tyramine Hydrogel via Enzyme-Mediated Reaction for Enhancement of Endothelial Cell Activity and Neovascularization
【24h】

In Situ SWYGLR Peptide Conjugation into Injectable Gelatin-Poly(ethylene glycol)-Tyramine Hydrogel via Enzyme-Mediated Reaction for Enhancement of Endothelial Cell Activity and Neovascularization

机译:通过酶介导原位SWYGLR肽缀合到可注射明胶-聚(乙二醇)-酪胺水凝胶中,以增强内皮细胞活性和新血管形成

获取原文
获取原文并翻译 | 示例
           

摘要

Tissue engineering therapies require biocompatible and bioactive biomaterials that are capable of encouraging an angiogenic response for effective tissue regeneration. In this study, a SWYGLR peptide, which functions as a potent angiogenic factor, was conjugated into injectable gelatin-poly(ethylene glycol)-tyramine (GPT) hydrogels in situ to enhance endothelial cell activities and neo-vascularization. SWYGLRGGY (SV-Y) conjugated GPT (SV—GPT) hydrogels were formed in situ via enzyme-mediated reaction using horseradish peroxidase (HRP) and hydrogen peroxide (H2O2). The physico-chemical properties were characterized and could be controlled depending on the feed peptide and H2O2 concentration. The concentration of conjugated peptide ranged from 0.37 to 0.81 μmol/mL, and the elastic moduli (G') of the hydrogels were 600-4900 Pa. In vitro cell studies using human umbilical vein endothelial cells (HUVECs) and in vivo subcutaneous injection studies were performed to confirm the effect of the SWYGLR peptide on HUVEC activity and neo-vascularization. Obtained results demonstrated that the in situ conjugation of SWYGLR sequences into phenol residues of GPT hydrogels enhanced the activity of HUVECs in vitro and stimulated the formation of new blood vessels in the hydrogel matrices in vivo. From the results, we suggest that in situ conjugation of SV-Y to GPT hydrogels via the enzymatic reaction may be an efficient tool to prepare injectable bioactive hydrogels that can enhance endothelial cell activities and promoting angiogenesis for tissue regeneration.
机译:组织工程疗法需要具有生物相容性和生物活性的生物材料,这些材料能够促进血管生成反应,以实现有效的组织再生。在这项研究中,SWYGLR肽,作为有效的血管生成因子,被缀合到可注射的明胶-聚(乙二醇)-酪胺(GPT)水凝胶中,以增强内皮细胞活性和新血管形成。使用辣根过氧化物酶(HRP)和过氧化氢(H2O2)通过酶介导的反应原位形成SWYGLRGGY(SV-Y)共轭GPT(SV-GPT)水凝胶。对理化性质进行了表征,可以根据进料肽和H2O2的浓度进行控制。结合肽的浓度范围为0.37至0.81μmol/ mL,水凝胶的弹性模量(G')为600-4900 Pa。使用人脐静脉内皮细胞(HUVEC)进行的体外细胞研究和体内皮下注射研究进行了证实SWYGLR肽对HUVEC活性和新血管形成的作用。获得的结果表明,SWYGLR序列在GPT水凝胶的酚残基中的原位缀合增强了HUVEC的体外活性,并在体内刺激了水凝胶基质中新血管的形成。从结果来看,我们建议通过酶促反应将SV-Y原位偶联至GPT水凝胶可能是制备可注射的生物活性水凝胶的有效工具,该水凝胶可增强内皮细胞的活性并促进组织再生的血管生成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号